Global Nasal Drug Delivery Systems Market- 2020-2027
Global Nasal Drug Delivery Systems Market is segmented By Application type (Delivery of non-peptide pharmaceuticals, Delivery of peptide pharmaceuticals, Delivery of diagnostic drugs, CNS delivery, Nasal vaccination), By Dosage forms type (Nasal drops, Nasal sprays, Nasal gels, Nasal suspensions & emulsions, Nasal micellar and liposomal formulations, Nasal powders, Nasal particles), By Formulation type (Drugs, Viscosifying agents, Solubilizers, Surfactants, Bio-adhesive polymers, Preservatives, Antioxidants), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027
Market Overview
The Global Nasal Drug Delivery Systems Market is expected to grow at a CAGR of 6.6% during the forecasting period (2020-2027).
Why Purchase the Report?
Visualize the composition of the Global Nasal Drug Delivery Systems Market in terms of various types of drug class, formulation type, and end-users highlighting the critical commercial assets and players.
Identify commercial opportunities in global Nasal Drug Delivery Systems Market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of global Nasal Drug Delivery Systems Market-level 4/5 segmentation.
A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
Target Audience
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
- 1. Global Nasal Drug Delivery Systems Market Methodology and Scope
- 1.1. Research methodology
- 1.2. Research Objective and Scope of the Report
- 2. Global Nasal Drug Delivery Systems Market – Market Definition and Overview
- 3. Global Nasal Drug Delivery Systems Market – Executive Summary
- 3.1. Market Snippet By Application type
- 3.2. Market Snippet By Dosage forms type
- 3.3. Market Snippet By Formulation type
- 3.4. DataM CLO Scenario
- 4. Global Nasal Drug Delivery Systems Market – Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rise in adoption of self-administration practices
- 4.1.1.2. Increasing preference for alternative mode of drug administration
- 4.1.1.3. Rising awareness about nasal products.
- 4.1.2. Restraints
- 4.1.2.1. Local toxicity
- 4.1.2.2. Restricted volume of nasal cavity
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Global Nasal Drug Delivery Systems Market – Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. Patent Analysis
- 6. Global Nasal Drug Delivery Systems Market – By Application type
- 6.1. Introduction
- 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type Segment
- 6.1.2. Market Attractiveness Index, By Product type Segment
- 6.2. Delivery of non-peptide pharmaceuticals
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 6.3. Delivery of peptide pharmaceuticals
- 6.4. Delivery of diagnostic drugs
- 6.5. CNS delivery
- 6.6. Nasal vaccination
- 7. Global Nasal Drug Delivery Systems Market – By Dosage forms type
- 7.1.1. Introduction
- 7.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation type Segment
- 7.1.3. Market Attractiveness Index, By Intubation type Segment
- 7.2. Nasal drops
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 7.3. Nasal sprays
- 7.4. Nasal gels
- 7.5. Nasal suspensions & emulsions
- 7.6. Nasal micellar and liposomal formulations
- 7.7. Nasal powders
- 7.8. Nasal particles
- 8. Global Nasal Drug Delivery Systems Market – By Formulation type
- 8.1.1. Introduction
- 8.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
- 8.1.3. Market Attractiveness Index, By Application Segment
- 8.2. Drugs
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 8.3. Viscosifying agents
- 8.4. Solubilizers
- 8.5. Surfactants
- 8.6. Bio-adhesive polymers
- 8.7. Preservatives
- 8.8. Antioxidants
- 9. Global Nasal Drug Delivery Systems Market – By Region
- 9.1.1. Introduction
- 9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- 9.1.3. Market Attractiveness Index, By Region
- 9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage forms
- 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation
- 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
- 9.2.6.1. U.S.
- 9.2.6.2. Canada
- 9.2.6.3. Mexico
- 9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage forms
- 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation
- 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
- 9.3.6.1. Germany
- 9.3.6.2. U.K.
- 9.3.6.3. France
- 9.3.6.4. Italy
- 9.3.6.5. Spain
- 9.3.6.6. Rest of Europe
- 9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage forms
- 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation
- 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
- 9.4.6.1. Brazil
- 9.4.6.2. Argentina
- 9.4.6.3. Rest of South America
- 9.5. Asia Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage forms
- 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation
- 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
- 9.5.6.1. China
- 9.5.6.2. India
- 9.5.6.3. Japan
- 9.5.6.4. Australia
- 9.5.6.5. Rest of Asia Pacific
- 9.6. The Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage forms
- 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation
- 10. Global Nasal Drug Delivery Systems Market – Competitive Landscape
- 10.1. Competitive Scenario
- 10.2. Competitor Strategy Analysis
- 10.3. Comparative Product Portfolio Analysis
- 10.4. Market Positioning/Share Analysis
- 10.5. Mergers and Acquisitions Analysis
- 11. Company Profiles
- 11.1. GlaxoSmithKline(GSK) PLC
- 11.1.1. Company overview
- 11.1.2. Product portfolio and description
- 11.1.3. Key highlights
- 11.1.4. Financial overview
- 11.2. AstraZeneca PLC
- 11.3. 3M Pharmaceuticals Inc.
- 11.4. Becton, Dickinson and Company
- 11.5. Johnson & Johnson
- 11.6. OptiNose Inc.
- 11.7. Novartis International AG
- 11.8. Promius Pharma LLC
- 11.9. Bausch Health
- 11.10. UCB
- 12. Global Nasal Drug Delivery Systems Market – Premium Insights
- 13. Global Nasal Drug Delivery Systems Market – DataM
- 13.1. Appendix
- 13.2. About Us and Services
- 13.3.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook